ライフサイエンスコーパス: cryosurgery

コーパス検索結果 (１語後でソート)

通し番号をクリックするとPubMedの該当ページを表示します

1 lone or in combination with open superficial cryosurgery.

2 ; 2 patients also underwent open superficial cryosurgery.

3 gate the MTD for patients who have undergone cryosurgery.

4 ization, percutaneous ethanol injection, and cryosurgery.

5 69 years) with prostate cancer who underwent cryosurgery.

6 % in patients examined 8 weeks or more after cryosurgery.

7 cinoma underwent endorectal MR imaging after cryosurgery.

8 en patients also underwent MR imaging before cryosurgery.

9 intralesional) alone or in combination with cryosurgery, allowing patients to continue therapy with

10 Long-term data are emerging to support cryosurgery, and large multicenter databases have been d

11 formal radiation therapy, brachytherapy, and cryosurgery), antiandrogen therapy management of erectil

12 All patients in the cryosurgery group responded, and seven of the eight cryo

13 Cryosurgery has a promising role in primary and salvage

14 ssful therapy and helped identify successful cryosurgery in patients who still had an elevated prosta

15 ential directions for future developments in cryosurgery include concepts to reduce side effects such

16 Cryosurgery-induced changes in the prostate gland preclu

17 Cryosurgery is a new method of treating prostate cancer.

18 gery group responded, and seven of the eight cryosurgery patients developed normal positron emission

19 The MTD for patients who did not undergo cryosurgery was 100 mg/m2 of irinotecan weekly for 3 wee

20 tial) among all patients who did not undergo cryosurgery was 74%.

21 cohorts of patients treated with or without cryosurgery were entered at escalating dose levels.

22 s) and cancer (2.4 +/- 1.0, 65 voxels) after cryosurgery were not statistically significantly differe

WebLSDに未収録の専門用語（用法）は "新規対訳" から投稿できます。